PRADEYROL DEVELOPMENT
Pradeyrol Development is a family office that invests in firms with great innovative potential, especially in the biotechnology sector where it aims at taking significant minority shares. Pradeyrol Développement entrusted Alexandre Le Vert (the CEO of Imaxio) with the task of broadening its Biotechnology portfolio by investing in companies mostly positioned in Immunology or Personalized Diagnostics and with respected management.
Similar Organizations
Commercial Development Bank
Commercial Development Bank is a banking firm that provides financial services.
Lind Invest
Lind Invest is a single-family office and long-term investor.
Turkey Development Fund
Turkey Development Fund aims to develop the enterprise ecosystem by investing in new generation startups.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-03-26 | Hybrigenics | Pradeyrol Development investment in Post-IPO Equity - Hybrigenics | 6.1 M EUR |
| 2013-10-16 | Hybrigenics | Pradeyrol Development investment in Post-IPO Equity - Hybrigenics | 1.3 M EUR |
More informations about "Pradeyrol Development"
PRADEYROL DEVELOPPEMENT Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PRADEYROL DEVELOPPEMENT of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & …See details»
Dr Christian Pradeyrol, MD - Osivax
Dr PRADEYROL is the Executive Chairman and Founder of Pradeyrol Développement, a family office actively investing in new technologies. With participations in a dozen of Biotech companies in France and in the US, …See details»
Pradeyrol Développement Company Profile, Financial and …
Pradeyrol Développement owns and operates a group of private clinics. The company was incorporated in 2007 and is based in Paris, France. digitGaps report on Pradeyrol …See details»
PRADEYROL DEVELOPPEMENT (PARIS) Chiffre d'affaires, résultat, …
PRADEYROL DEVELOPPEMENT, société civile, au capital social de 124740960,00 EURO, dont le siège social est situé au 5 RUE SAINT-ROCH, 75001 PARIS, immatriculée au Registre du …See details»
Société PRADEYROL DEVELOPPEMENT : Chiffre d'affaires ... - Pappers
Jun 9, 2025 PRADEYROL DEVELOPPEMENT à PARIS (75001) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS ...See details»
Pradeyrol Développement Family Office - Single Profile | Preqin
Pradeyrol Développement is a corporate investor that invests in firms with innovative potential, especially in the biotechnology sector, focusing mainly on vaccines and molecular diagnostics.See details»
Pradeyrol Development – Investors Database – Unicorn Nest
Discover reliable insights Leverage validated data, identify key contacts and secure funding opportunities for your business.See details»
Pradeyrol Développement se soigne dans la région de Briançon
Jun 11, 2012 Dans le cadre d'un reclassement de titres, Pradeyrol Développement reprend 66 % de Les Acacias Centre Des Maladies Respiratoires et Allergiques, à la famille fondatrice - qui …See details»
Pradeyrol Developpement - BioCentury Company Profiles - BCIQ
Apr 7, 2014 Pradeyrol Developpement - BioCentury Company Profiles for the biopharma industrySee details»
Pradeyrol Development - Financial Details - Crunchbase
Pradeyrol Development is a family office actively investing in new technologies.See details»
Christian Pradeyrol : PRADEYROL DEVELOPPEMENT - Pappers
Feb 29, 2008 PRADEYROL DEVELOPPEMENT - 499 588 994 Gérant et associé indéfiniment responsable depuis le 16/08/2007 Date de création : 02/08/2007 Forme juridique : Autre …See details»
Christian Pradeyrol - Crunchbase Person Profile
Dr. Christian PRADEYROL is Chairman of the Board of IMAXIO and CEO. Since 2007, Dr. PRADEYROL is Executive Chairman and founder of Pradeyrol Développement, a family office …See details»
Pradeyrol Development - Investments, Portfolio & Company Exits
Mar 26, 2014 Pradeyrol Development is a family office actively investing in new technologies.See details»
Pradeyrol Développement - Maddyness - Le média pour …
Rayonnez auprès d’une audience ultra-qualifiée grâce à notre solution sur-mesure pour toucher les LPs et entrepreneurs de la tech. Nous contacter MDVC premium Boostez la visibilité de …See details»
InnaVirVax lands $4.9 Million in Series B funding Round
Feb 14, 2012 InnaVirVax lands $4.9 Million in Series B funding Round This second round of funding was lead by the Pradeyrol Développement family office along with the private equity …See details»
PRADEYROL DEVELOPPEMENT - Societe.com
L'entreprise PRADEYROL DEVELOPPEMENT a actuellement domicilié son établissement principal à PARIS 1 (siège social de l'entreprise). C'est l'établissement où sont centralisées …See details»
Pradeyrol Développement refinance Imaxio | Capital Finance
Apr 23, 2012 La jeune biotech parisienne Imaxio, principalement active à Lyon et à Clermont-Ferrand, vient d'annoncer que son actionnaire de référence Pradeyrol Développement, le …See details»
Prosperity and Growth Strategy for Northern Ontario 2025-2030
1 day ago Background The Prosperity and Growth Strategy for Northern Ontario (PGSNO) is led by the Federal Economic Development Agency for Northern Ontario (FedNor) and reflects a …See details»
Osivax Receives Over EUR 30M in Public Funding to Support …
Lyon, France – July 08, 2020 – Osivax announced today that it has received over EUR 30M in public funding from different sources to support the development of universal vaccines against …See details»
Government of Canada launching update of regional growth …
1 day ago The Prosperity & Growth Strategy for Northern Ontario (PGSNO) is a comprehensive document intended to support and amplify current and ongoing Government of Canada …See details»